Solubilization of Cationic Drugs in Lung Surfactant

Pharmaceutical Research

Volumn 20, Issue 11, 2003, Pages 1858-1863

  Liao, Xiangmin ^a   Wiedmann, Timothy S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Lung surfactant; Partition coefficient; Phenothiazines; pKa; Solubilization

Indexed keywords

AMITRIPTYLINE; IMIPRAMINE; LUNG SURFACTANT; MEPACRINE; PROMAZINE; PROMETHAZINE; PROPRANOLOL;

ABSORPTION SPECTROPHOTOMETRY; ALKALINITY; AQUEOUS SOLUTION; ARTICLE; CENTRIFUGATION; DIELECTRIC CONSTANT; DISSOCIATION CONSTANT; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG RETENTION; DRUG SOLUBILITY; ENTHALPY; ENTROPY; HYDROPHOBICITY; PRIORITY JOURNAL; SOLUBILIZATION; STATISTICAL SIGNIFICANCE; STEREOCHEMISTRY; THERMODYNAMICS;

CATIONS; HYDROPHOBICITY; PHARMACEUTICAL PREPARATIONS; PULMONARY SURFACTANTS; SOLUBILITY;

EID: 0344514876     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000003386.33834.cd     Document Type: Article

References (18)

1. R. H. Notter. Lung Surfactants. Basic Science and Clinical Applications, Marcel Dekker, Inc. New York, 2000.
2. S. M. McAllister, H. O. Alpar, Z. Teitelbaum, and D. B. Bennett. Do interactions with phospholipids contribute to the prolonged retention of polypepetides within the lung? Adv. Drug. Del. Rev. 19:89-110 (1996).
3. T. S. Wiedmann, R. Bhatia, and L. W. Wattenberg. Drug solubilization in lung surfactant. J. Control. Rel. 65:43-47 (2000).
4. S. Pham and T. S. Wiedmann. Dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant. J. Pharm. Sci. 90:98-104 (2001).
5. R. N. Upton and D. J. Doolette. Kinetic aspects of drug disposition in the lungs. Clin. Exp. Pharmacol. Physiol. 26:381-391 (1999).
6. M. S. Rose, E. A. Lock, L. L. Smith, and I. Wyatt. Paraquat accumulation: tissue and species specificity. Biochem. Pharmacol. 25:419-423 (1976).
7. Z. Wu, P. Upadhyaya, S. G. Carmella, S. S. Hecht, and C. L. Zimmerman. Disposition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in bile duct-cannulated rats: Stereroselective metabolism and tissue distribution. Carcinogenesis 23:171-179 (2002).
8. P. S. Chen Jr., T. Y. Toribara, and H. Warner. Phosphorus determiniation. Anal. Chem. 28:1756-1758 (1956).
9. K. E. Reilly, A. J. Mautone, and R. Mendelsohn. Fourier-transform infrared spectroscopy studies of lipid/protein interaction in pulmonary surfactant. Biochemistry 28:7368-7373 (1989).
10. K. A. Connors. In "A textbook of pharmaceutical analysis," 2nd ed., John Wiley & Sons: New York, 1975, pp. 131.
11. A. Albert and E. P. Serjeant. The determination of ionization constants. Chapman and Hall Ltd., New Fetter Lane, London, 1971, pp. 44-60.
12. M. S. Fernandez and P. Fromherz. Lipoid pH indicators as probes of electrical potential and polarity in micelles. J. Phys. Chem. 81:1755-1761 (1977).
13. C. J. Drummond, F. Grieser, and T. W. Healy. Acid-base equilibria in aqueous micellar solutions. Faraday Disc. Chem. Soc. 81:95-106 (1986).
14. J. T. Rubino and W. W. Berryhill. Effects of solvent polarity on the acid dissociation constants of benzoic acids. Pharm. Res. 75: 182-186 (1986).
15. A. Bratts and B. I. Axelsson. Inhaled glucocorticosteroids in asthma. In R. P. Schleima, W. W. Busse, and P. M. O'Byrne (eds), Mechanisms and clinical actions. Lung Biology in Health and Disease 97, Marcel Dekker, New York, 1995, 351-379.
16. G. Hochhaus, H. Mollmann, H. Derendorf, and R. J. Gonzalez-Roth. Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model. J. Clin. Pharm. 37:881-892 (1997).
17. S. Suarez, R. J. Gonzalez-Rothi, H. Schreier, and G. Hochhaus. Effect of dose release rate on pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm. Res. 15:461-465 (1998).
18. R. J. Gonzalez-Rothi, S. Suarez, G. Hochhaus, H. Schreier, A. Lukyanov, H. Derendorf, and T. D. Costa. Pulmonary targeting of liposomal triamcinolone acetonide phosphate. Pharm. Res. 13: 1699-1703 (1999).